AbCellera Biologics Inc. ABCL Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s interest income?
- AbCellera Biologics Inc. (ABCL) reported interest income of $3.64M in Q1 2026.
- How has AbCellera Biologics Inc.'s interest income changed year-over-year?
- AbCellera Biologics Inc.'s interest income decreased by 34.0% year-over-year, from $5.52M to $3.64M.
- What is the long-term trend for AbCellera Biologics Inc.'s interest income?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s interest income has grown at a 66.8% compound annual growth rate (CAGR), from $3.33M to $25.8M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.